Fibroplasia and angiogenesis are essential components of tissue repair when substantial tissue has been lost at a site of injury. Platelets and monocyte/macrophages accumulate at these sites and release a variety of growth factors that are thought to initiate and sustain the repair. Often the involved tissue contracts, a process that can markedly reduce the amount of fibroplasia and angiogenesis necessary for the reestablishment of organ integrity. Such tissue contraction occurs over hours or days, a much slower time course than the rapid, reversible contraction of muscle tissue. Fibroblasts, which are rich in f-actin bundles, appear to be responsible for wound contraction. However, the signals that stimulate contraction are not known. Using cultured fibroblasts, which are also rich in f-actin bundles, we demonstrate the platelet and monocyte isoforms of platelet-derived growth factor (PDGF; AB and BB) but not PDGF-AA, can stimulate fibroblasts to contract collagen matrix in a time course similar to that of wound contraction. In addition, PDGF appears to be the predominant fibroblast/collagen gel contraction activity released from platelets. Vasoactive agonists known to stimulate smooth and striated muscle contraction do not stimulate fibroblast-driven collagen gel contraction.
Introduction
When substantial tissue loss occurs after injury, fibroblast ingrowth, connective tissue deposition, and angiogenesis, often in concert with tissue contraction, reestablish organ integrity (1, 2) . Using explants from 1-2-wk wounds, Gabbiani et al. (3) demonstrated that ex vivo granulation tissue contraction was actin dependent. The actin-rich cells in wound tissue have been characterized as specialized fibroblasts called myofibroblasts (4) . This same fibroblast phenotype has been observed in tissue taken from patients with a variety of fibrocontractive diseases (2) . Thus, f-actin-rich fibroblasts may also be responsible for the very slow, progressive tissue contraction observed in scleroderma, constrictive pericarditis and myocarditis, pulmonary fibrosis, and liver cirrhosis.
The so-called myofibroblast contains large f-actin bundles that course longitudinally along the cytoplasmic faQe of the plasma membrane in the direction of the major cell axis. In wounds the intracellular actin bundles are aligned with extracellular fibronectin fibrils across the radial axis of the wound. These networks ofintra-and extracellular microfilaments may be responsible for transmitting the collective force generated by fibroblasts across the tissue (5) . Although the biomechanics by which this type of tissue contraction may occur have been investigated, little is known about the signals that stimulate such contraction. Platelet-derived growth factor (PDGF)-BBI and -AB are presumed to be released from platelets and monocyte/macrophages at sites of tissue injury (1). Since PDGF is known to stimulate fibroblast migration (6, 7) and proliferation (8) , and arterial smooth muscle contraction (9), we investigated the ability of PDGF to initiate fibroblast contraction of collagen matrix.
Cultured fibroblasts mixed with soluble collagen, which is then allowed to gel, contract the collagen matrix over the course of several days when serum is added to the culture (10) . Like granulation tissue contraction, fibroblast-driven collagen gel contraction is actin dependent (ld). In addition, fibronectin-containing microfibrils interconnect cultured fibroblasts (11) and are aligned with intracellular f-actin bundles (12) . Because of the similarities between the in vitro system and contracting wound tissue, Bell et al. have proposed that fibroblast-contracted collagen gels represent a tissue-equivalent construct (10, 13 (10, 15, 16) , to follow reduction in gel area. In addition, we have confirmed that the degree of fibroblast-driven collagen gel contraction is positively correlated with the number of fibroblasts added to the collagen and inversely proportional to the collagen concentration as previously reported by Bell et al. (10) .
Ycoechst dye assayfor DNA. Proliferation of fibroblasts in collagen gels was monitored by a modified Hoechst dye fluorescence assay for DNA (17) . Aliquots of sonicated fibroblasts and collagen gel were diluted 10-fold in a pH 7.4 buffer containing 10 mM NaH2PO4, 4 M NaCl, and 2 mM EDTA. The suspension was vortexed vigorously and clarified by centrifugation at 9,500 g for 5 (18) . Recombinant DNA-derived PDGF-AA and -BB were isolated from a yeast expression system (18) .
-AA, stimulated fibroblast-driven collagen gel contraction (Fig. 1 B) . To document that all PDGF preparations used in this study were biologically active, we measured [3H]thymidine incorporation of fibroblasts plated on tissue culture plastic dishes and incubated 24 h in the presence of the various PDGF isoforms (see Methods). All PDGF isoform preparations stimulated DNA synthesis in a dose-response profile (Fig.  2 ) similar to that recently reported by Raines et al. (19) .
To determine whether other factors released from platelets could stimulate fibroblast-driven collagen gel contraction, platelets were isolated from plasma by centrifugation at 900 g for 10 min (20) . Washed platelets were resuspended in 20 mM Tris, 145 mM NaCl, 5 mM KCI, 5 mM glucose, 2.5 mM EDTA, pH 7.5, at a volume of 5 ml/original unit of platelets. They were stimulated to release their products with 7 U/ml thrombin at room temperature. After 15 min platelets were centrifuged at 22,000 g for 20 min at 4°C and the supernatant containing the released platelet products (platelet releasate) was collected and stored at -20°C until used. Protein concentration of platelet releasate was determined by the Lowry technique (21) . Fig. 3 A demonstrates that increasing amounts of the platelet-released protein stimulated increasing degrees of fibroblast-driven gel contraction.
The question remained, however, whether PDGF was the only active factor in platelet releasate. To examine this question we constructed an anti-PDGF antibody affinity column. The MAb 121.6.1.1.1 (22) (23) . As shown in Fig. 3 B, PDGF-depleted releasate failed to stimulate contraction. In contrast, when platelet releasates were passed over a nonimmune IgG affinity column (sham depletion), the activity that stimulated gel contraction was not removed. When PDGF was eluted from the anti-PDGF affinity column and added back to PDGF-depleted platelet releasates to a final concentration ofthe original releasate (30 ng/ml), the contractile activity was restored (Fig.  3 B) . Thus, PDGF appeared to be the major factor in platelet releasates that stimulated fibroblast-driven collagen gel contraction.
Growth factors and cytokines are known to induce other A Figure 3 . growth factors and cytokines which may subsequently accumulate in cell culture (19, (24) (25) (26) . Therefore, we have presented our gel contraction data in a log time scale to emphasize the first 5 h after addition of a test substance to minimize such cascade events. The recent finding that transforming growth factor beta (TGF-beta) stimulated fibroblast contraction of collagen gels after a 24-h delay (27) underscores the importance of potential sequential events. That is, the delayed response may be related to the ability of TGF-beta to induce PDGF mRNA and protein synthesis (24) . As shown in Table I , little or no collagen contraction was observed with 10 or 30 ng/ml TGF-beta (Collagen Corp., Palo Alto, CA) (28) at 4 or 24 h after addition to our system. On the other hand, a 45±5.0% decrease in gel area was observed at 48 h with 30 ng/ml TGF-beta. In addition to TGF-beta, we have examined other growth factors and autacoids for their ability to stimulate fibroblast-driven gel contraction (Table I) 
Discussion
We demonstrated in this report that fibroblast-driven collagen gel contraction is stimulated by the platelet isoforms of PDGF (AB and BB) but not by PDGF-AA. Furthermore, the fibroblast/gel contraction response to PDGF was separable from PDGF stimulation of fibroblast proliferation. Since fibroblastdriven contraction of collagen gels has been demonstrated to be actin dependent (10) , the fibroblast/gel contraction response to PDGF is probably related to other actin-dependent cellular responses to PDGF such as chemotaxis (6, 7) and vascular smooth muscle cell contraction (9) . In fact, others (30, 31) have dissociated the chemotactic and mitogenic activi- From our experiments on platelet releasates, it appears that PDGF is responsible for most, if not all, of the fibroblast/collagen gel contractile activity. Recently another platelet product, TGF-beta, has also been shown to stimulate fibroblastdriven collagen gel contraction (27). However, the contractile response to TGF-beta does not occur until 24-48 h after its addition (27, confirmed in this study). This delay allows sufficient time for TGF-beta to induce de novo synthesis of PDGF, a well-documented response of fibroblasts to TGF-beta (24) . In contrast to the delayed time course of contraction seen with TGF-beta, platelet releasates and PDGF stimulated contraction by 2-5 h after addition ( Figs. 1 and 2 A) . The difference in time course coupled with the well-known fact that TGF-beta is released from platelets in a stable, latent form, whether in vitro or in vivo during blood coagulation (25), make TGF-beta a highly unlikely candidate for the gel-contracting activity found in platelet releasates.
PDGF may promote tissue repair through at least two distinct processes with either beneficial or detrimental outcomes. First, it is well established that PDGF stimulates fibroblast and smooth muscle cell expansion (8) and migration (6, 7) . Such mesenchymal cell ingrowth in vivo can be beneficial due to the repopulation of a space created by tissue loss. On the other hand, mesenchymal cell ingrowth can be detrimental because of invasion of a physiologically functional space (e.g., encroachment of a smooth muscle-rich atheromatous plaque into a blood vessel lumen, or invasion of fibroblasts into respiratory airways and lung alveoli after pulmonary injury). Second, PDGF stimulates fibroblast-driven contraction of collagen gel matrix as demonstrated in this report. Tissue contraction can be beneficial vis a vis reducing the amount of fibroplasia and angiogenesis needed to reestablish organ integrity after tissue loss. On the other hand, tissue contraction can be detrimental vis a vis reduction of physiologically functional space (e.g., joint contracture, bowel obstruction, esophageal constriction, pulmonary fibrosis, constrictive pericarditis/ myocarditis). Through future studies we hope to determine whether PDGF is responsible for stimulating tissue contraction in these various situations and what modulatory mechanisms exist for such activity. A better understanding of nonmuscle tissue contraction may allow appropriate intervention in wound repair and fibrocontractive disorders.
